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Objective: To analyse the epidemiology of otosclerosis in a
British cohort collected between 2011 and 2017.
Design: Retrospective cohort study.
Setting: Five UK ENT Departments.
Patients: Patients with surgically confirmed otosclerosis.
Main Outcome Measures: Questionnaire data documented
family history of otosclerosis, age of onset, medical history,
and information on associated risk factors for 657 patients.
Pre and post-surgical pure-tone audiometry was collected for
154 of these patients.
Results: The age of onset, incidence of bilateral disease,
tinnitus and vertigo, a higher prevalence of women (65%) than
men (35%) are similar to those reported previously for
otosclerosis cohorts. No association with measles infection
was detected. Patients with a family history (40%) have an
earlier age of onset and a higher incidence of bilateral disease
and vertigo than non-familial subjects. Pedigree analysis is
consistent with an autosomal dominant inheritance with
reduced penetrance being apparent in 44/91 pedigrees studied.
Women who associate their hearing loss with pregnancy have
an earlier age of onset than those that do not ( p¼ 6 106).
Conclusions: This study confirms that otosclerosis is an
early adult onset disease that is more prevalent in women
than men with a large minority of patients having a family
history of otosclerosis. We report new evidence to support a
relationship between pregnancy and otosclerosis progression
in a proportion of women. In addition, this is the first study
to identify differences in severity between familial and non-
familial cases of otosclerosis, highlighting the possibility that
more than one etiology may be involved. Key
Words: Bone remodeling—Epidemiology—Hearing loss—
Middle ear—Otosclerosis—Stapes surgery.
Otol Neurotol 40:22–30, 2019.
Otosclerosis is a common form of adult-onset hearing
impairment, typically characterized by disordered bone
remodeling in the otic capsule that leads to a progressive
conductive hearing loss. The remodeling process often
involves the stapedio-vestibular interface and can lead to
fixation of the stapedial footplate. Patients often choose
to undergo surgical treatment, by means of stapedectomy
or stapedotomy. Both techniques are successful in
improving the hearing loss to varying degrees (1).
Although many patients with otosclerosis select surgical
treatment, use of hearing aids to manage the hearing loss
are advised before surgery and are an alternative for
patients who are not candidates for stapes surgery (2–4).
Clinical otosclerosis is relatively common in White
Europeans with a reported frequency of 0.1 to 2.1%, and
is also common among individuals of Indian extraction
(5–9). The age of onset is variable, although hearing loss
typically begins in the third decade, with a range from
first decade to the sixth decade (5,7,10). In most cases,
hearing loss is bilateral (70–85%) and is usually asym-
metrical, developing initially in one ear before progress-
ing to the other (1,11–13). Otosclerosis has traditionally
been regarded as a middle-ear disease but the inner ear
can also be affected, with mixed or pure sensorineural
hearing loss, tinnitus and sometimes vertigo (14,15).
Otosclerosis is considered a complex disease with both
genetic and environmental factors that can occur in
isolated cases with no family history (non-familial), or
in cases with a strong familial inheritance pattern
consistent with a monogenic cause (familial). A posi-
tive family history of otosclerosis has been previously
reported in between 30 and 70% of cases (5,10,11,16,17).
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This wide range probably reflects a recruitment bias in
these cohorts and variable ascertainment of relatives of
the proband. The pattern of inheritance in familial oto-
sclerosis is most often consistent with an autosomal
dominant mutation that exhibits variable penetrance.
Although reduced penetrance is common, the degree
of penetrance can vary greatly between families and
has been reported between 40 and 90% (5,10,18–23).
To date, otosclerosis has proved resistant to analysis by
conventional genetic techniques such as linkage analysis.
In 2009, a genome-wide association study identified an
association between RELN and otosclerosis (24), how-
ever, its biological role remains unclear. Recently, muta-
tions and altered expression of SERPINF1 have been
identified in patients with familial otosclerosis (25).
In addition to the genetic component of otosclerosis,
various other etiological factors have been suggested as
playing a role in the pathogenesis of otosclerosis over the
years. Clinical otosclerosis is consistently reported as
more prevalent in women than in men, giving rise to the
hypothesis that sex hormones may contribute to the
development of disease (26–29). Other factors which
have been associated with otosclerosis incidence include
measles-virus infection (30–36), fluoride in drinking
water (37), and co-incidence with certain systemic con-
nective tissue disorders (38,39). However, despite its
long history, many questions regarding the etiology of
this condition remain unclear. One reason for this is a
scarcity of empirical data on the epidemiology of oto-
sclerosis in large well characterized cohorts. Although
there have been several reviews of otosclerosis literature
in recent decades which have included reiterations of the
established epidemiology, these are largely based on a
relatively limited number of studies some of which date
back as far as the 1950s (5,10,16,18). There is therefore a
need for a new analysis of otosclerosis epidemiology in
sizeable cohorts to confirm or refute the conclusions
inherited from much earlier studies.
The aim of this study was to report the epidemiological
findings from a British cohort recently recruited for a
genetic study of otosclerosis (25) and examine factors
such as age of onset, pattern of inheritance, hearing loss
symptoms, as well as investigate the differences between
the various demographic subgroups of the cohort including
sex, familial inheritance, and pregnancy characteristics to
reveal any potentially distinct pathological mechanisms.
METHODS
Patient Recruitment
Between 2011 and 2017 individuals with a confirmed diag-
nosis of otosclerosis were recruited from the Royal National
Throat Nose and Ear Hospital (London), Princess Margaret
Hospital (Windsor), Sunderland Royal Hospital (Sunderland),
Freeman Hospital (Newcastle upon Tyne), and Ninewells Hos-
pital (Dundee). The diagnosis of otosclerosis was made on
clinical and audiometric examination, and then confirmed
during surgery. Two recruitment pipelines were used, one
via individuals attending for surgical treatment and another
involved a retrospective recruitment of past surgical patients
from the same centres. The study was approved by the London
Bloomsbury NRES Ethics committee (11/LO/0489) and
patients were recruited by informed consent. Patient reported
outcomes were recorded using a structured questionnaire
regarding medical history (see Supplemental Digital Content
1, http://links.lww.com/MAO/A688). All female subjects
answered a second questionnaire detailing history of pregnan-
cies and hormonal medication use (see Supplemental Digital
Content 2, http://links.lww.com/MAO/A689).
Family Pedigrees
In 96 patients who reported a strong family history of otoscle-
rosis a family pedigree was constructed based on further investi-
gationwith the proband and recruitment of other familymembers
to the study.We investigated at least three generations per family
and following detailed assessment, a pattern of inheritance was
assigned for each pedigree. The number of affected parents of
probands was used to estimate the penetrance in otosclerosis.
Audiometry
Pure-tone audiometry was performed not earlier than
3 months before surgery and 3 months after. Air-conduction
(AC) and bone-conduction (BC) included frequencies 0.5, 1, 2,
3 and 4 kHz. The guidelines from the Committee on Hearing
and Equilibrium regarding the four-tone pure-tone average (0.5,
1, 2, and 3 kHz) were followed (40). Pure-tone average (PTA)
values (0.5, 1, 2, and 3 kHz) were calculated regarding AC and
BC thresholds, as well as the air-bone gap (ABG). We used the
parameters of successful surgery as: postoperative ABG less
than or equal to 10 dB; AC improvement more than or equal to
20 dB; or BC not worsened by more than or equal to 5 dB (41).
Data Analysis
Univariate analyses were performed on questionnaire data,
comparing different demographics using the x2 test. Audiometric
data were analyzed to establish normal distribution and Student’s
t-tests were conducted to establish if data were significant.
Results with values of p< 0.05 were considered statistically
significant. SigmaPlot 11.0 software (Systat Software Inc., San
Jose, CA) was used to perform all statistical analysis.
RESULTS AND DISCUSSION
Characteristics of the Study Cohort
A total of 1,025 subjects with a confirmed diagnosis of
otosclerosis were invited to join the study: 368 either
declined to take part or did not respond to a written
invitation (36%). Questionnaire data were obtained from
a total of 657 subjects and the cohort demographics are
summarized in Table 1.
The characteristics of this British otosclerosis cohort
are largely consistent with those of other published
otosclerosis cohorts and the reported epidemiology of
otosclerosis (5,10,11). As has been reported previously
there are more women (65%) than men in this British
cohort. Regarding ethnicity, the make-up of the cohort is
very similar to the ethnicities reported for the UK popu-
lation in the 2011 UK Census (n¼ 63,182,178) of 86%
White/White British, 7% Asian/Asian British, and 3%
Black/Black British (42). Most participants report the age
of onset of the disease as in the 3rd and 4th decades (62%,
Fig. 1A), with onset above the age of 50 (4%) or below
the age of 10 (6%) being rare. Familial clustering has
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long been identified in otosclerosis with evidence of a
monogenic, reduced penetrance familial form of the
disease proposed to exist alongside the more common
sporadic disease (5,10,11,16,17), and as in other cohorts a
large minority of patients (40%) report having at least
one other family member diagnosed with otosclerosis,
although only 16% of cases report having at least two
affected family members.
Although most patients in our cohort have bilateral
disease (62%) this is lower than the often quoted figure of
70 to 85% (1,11,12). In addition, most patients report
suffering from tinnitus (68%) and a significant minority
of subjects also reported symptoms of vertigo (31%). The
incidence of tinnitus in our cohort is consistent with
figures found in the literature of 50 to 85% (16,43,44).
However, the incidence of vertigo is higher than the 9 to
24% found in previous studies (11,16,43).
We examined the progression of symptoms with
increased duration of hearing loss (Fig. 1B). In patients
who had less than 10 years of hearing loss, 45% of
subjects reported bilateral symptoms, with this figure
increasing to 70 to 85% of subjects after more than
30 years of hearing loss, which is in line with what is
found in published literature. Incidence of vertigo also
increased from 25 to 45% with duration of hearing loss.
The relationship with tinnitus over time is less clear,
which may be a result of improved hearing after surgery.
FIG. 1. Characteristics of otosclerosis cohort. (A) Age of onset and (B) incidence of hearing phenotypes in otosclerosis cohort according to
duration of hearing loss (n¼657). (C) Age of onset and (D) incidence of bilateral hearing loss inmale and female cases according to duration
of hearing loss (male, n¼233; female; n¼424). (E) Age of onset and (F) bilateral hearing loss in familial and non-familial cases according to
duration of hearing loss (familial, n¼265; non-familial; n¼392). Familial caseswere defined as having 1 or more affected family member. ns
indicates not significant; , p<0.05; , p<0.01.
TABLE 1. Demographic characteristics of otosclerosis
cohort.
Variables n¼ 657
Sex Male
Female
35%
65%
Age at consent Years (meanSD) 50 13.3
Ethnicity White/White British
Asian/Asian British
Black/Black British
Other
No entry
85%
7%
3%
2%
3%
Age of onset 10 years
11–20 years
21–30 years
31–40 years
41–50 years
51 years
6%
11%
30%
32%
17%
4%
Family history 2 family members
1 family member
No family history
16%
24%
60%
Hearing loss Bilateral
Unilateral
No entry/DK (n¼ 13)
62%
38%
Tinnitus Yes
No
No entry/DK (n¼ 10)
68%
32%
Vertigo Yes
No
No entry/DK (n¼ 22)
31%
69%
DK indicates do not know; SD, standard deviation.
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Sex and Otosclerosis
There are a greater number of women than men in the
cohort with a ratio of 1.9:1, which is in keeping with
previous reports of a sex bias of 1.5 to 2:1 in the female to
male prevalence of otosclerosis (11,41,45,46). Dichoto-
mising this British cohort by sex (Table 2) shows that the
age of women at recruitment and self-reported age of
onset is not significantly different from men (Fig. 1C).
Furthermore, there is evidence that women experience
greater severity of symptoms at an earlier age than men.
Women report significantly higher rates of bilateral
disease ( p¼ 0.03), tinnitus ( p¼ 0.02), and a greater
incidence of vertigo although this latter difference is
not statistically significant ( p¼ 0.06). The higher rate
of bilateral disease in women was maintained throughout
progression of the disease although was only statistically
significant at two time-points (Fig. 1D).
It has previously been proposed that the greater prev-
alence of women in otosclerosis cohorts might be
explained by women seeking earlier clinical treatment
than men (47). However, the consistency and degree of
the female bias across different cohorts seems unlikely to
be fully explained by this factor leading to the hypothesis
that estrogen may play a role in the etiology of the
disorder (26–29). In our cohort the similar age of onset
reported in men and women does not support an earlier
attendance of women in audiological clinics and instead
is more consistent with the hypothesis that women are at
a higher risk of developing clinical otosclerosis than men.
Familial Inheritance and Otosclerosis
Otosclerosis is unusual in that in some populations it is
a relatively common disorder with a familial form of the
disease that is thought to have a monogenic origin, and a
non-familial form. We examined the profile of otoscle-
rosis comparing familial and non-familial cases
(Table 2). Familial cases were defined as having one
or more family members with otosclerosis. No significant
differences were observed between familial cases with
one affected relative and familial cases with two or more
affected relatives (Table S1, Supplemental Digital Con-
tent 3, http://links.lww.com/MAO/A690).
The age at recruitment of familial cases was older
than non-familial cases by an average of 3 years
( p¼ 8 10–3). Two recruitment pipelines were used,
one via individuals attending for surgical treatment and
another involved a retrospective recruitment of past
surgical patients. Patients recruited retrospectively
are therefore likely to be older than those recruited at
surgery. Therefore, we examined the characteristics
of our cohort comparing surgical and retrospective
recruitment (Table S2, Supplemental Digital Content
3, http://links.lww.com/MAO/A690). The age at
recruitment of the retrospective cases was significantly
older than surgical cases (55 and 48 yr, respectively,
p¼ 1 10–9). A significant difference is also observed
in the reporting of family history, where 35% of
current surgical cases compared with 51% of retrospec-
tive cases report a family history of otosclerosis
( p¼ 2 104). It is therefore possible that the older
age of familial patients at recruitment may be explained
by a greater motivation of patients with family history
to respond to the retrospective recruitment method and
hence, that 35% represents a better estimate of familial
incidence. This also highlights why such a wide range is
observed in the published literature, with a positive
TABLE 2. Demographic characteristics of otosclerosis cohort stratified by sex and family history
Variables Male (n¼ 233) Female (n¼ 424) p-value Familial (n¼ 265) Non-familial (n¼ 392) p-value
Sex Male
Female
n/a n/a n/a 33%
67%
37%
63%
0.36
Age at consent Years (meanSD) 51 12.7 50 13.6 0.23 52 13.5 49 13.1 8T 10S3
Ethnicity White/White British
Asian/Asian British
Black/Black British
Other
No entry
85%
7%
3%
1%
4%
84%
8%
2%
4%
2%
0.11 86%
8%
2%
2%
2%
84%
7%
3%
3%
3%
0.85
Age of onset 10 years
11–20 years
21–30 years
31–40 years
41–50 years
51 years
7%
10%
23%
35%
21%
4%
6%
11%
33%
30%
16%
4%
0.11 4%
14%
34%
29%
14%
5%
8%
8%
27%
34%
20%
3%
6T 10S3
Family history Familial
Non-familial
38%
62%
42%
58%
0.36 n/a n/a n/a
Hearing loss Bilateral
Unilateral
56%
44%
66%
34%
0.03 69%
31%
58%
42%
6T 10S3
Tinnitus Yes
No
62%
38%
72%
28%
0.02 70%
30%
67%
33%
0.47
Vertigo Yes
No
26%
74%
33%
67%
0.06 36%
64%
28%
72%
0.04
Familial cases were defined as having one or more affected family member. SD indicates standard deviation. Significant differences in bold.
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family history reported between 30 and 70% of cases
(5,10,11,16,17), and probably reflects a recruitment
bias within the cohorts.
Despite the older age at recruitment familial patients
report a significantly earlier age of onset than non-familial
subjects with a mode age of onset in the 3rd decade
compared with 4th decade for non-familial patients
( p¼ 6 103; Fig. 1E). Familial patients also report a
higher incidence of bilateral disease and vertigo than non-
familial subjects consistent with an earlier, more severe
disease ( p¼ 6 103 and p¼ 0.04, respectively). Inci-
dences of tinnitus were similar in both groups. As familial
subjects reported significantly higher rates of bilateral
disease, we looked at the correlation between the duration
and bilaterality of hearing loss in familial and non-familial
participants (Fig. 1F). In those patients who reported
hearing loss for between 11 and 20 years, familial subjects
reported significantly higher rates of bilateral disease
compared with non-familial (70% and 53%, respectively,
p¼ 0.02). This difference was not observed after a longer
duration of otosclerosis but suggests familial otosclerosis
may be quicker to progress to bilateral disease.
Previous studies have suggested the possibility of a
differing etiology for the two forms of otosclerosis
(5,43). However, most studies have not documented fam-
ily history and therefore did not compare the character-
istics of familial and non-familial cases of otosclerosis. In
2001, one study that evaluated a relatively small retro-
spective cohort of 183 patients found no difference in the
degree of clinical severity between sporadic and familial
cases (43). This may explain why this is the first study to
report that familial patients have a significantly earlier age
of onset, and report a higher incidence of bilateral disease
and vertigo than non-familial subjects, consistent with an
earlier, more severe disease in familial cases suggesting
that distinct pathological mechanisms may be involved.
Pedigree Analysis
Otosclerosis is commonly described as having an
autosomal dominant mode of inheritance, with evidence
of incomplete penetrance (5,10,18,19), although the
empirical evidence available to support this is limited.
To investigate the inheritance pattern of familial otoscle-
rosis in our cohort, family pedigrees were constructed
from 96 patients who reported a strong family history of
otosclerosis. In 91 of the 96 families the apparent mode of
inheritance was most consistent with an autosomal dom-
inant pattern, with evidence of incomplete penetrance
observed in 44 of these 91 families. The remaining five
families having insufficient information to ascribe a
mode of inheritance. In estimating the degree of pene-
trance in otosclerosis, we examined the number of
affected parents of probands. Of the 96 pedigree pro-
bands, there are 62 affected parents indicating an esti-
mated penetrance of at least 65%. Before this study very
little data has been published since the 1980s regarding
the commonly recognized mode of inheritance found in
the literature. Therefore, our study is important in estab-
lishing this further.
Pregnancy, Breastfeeding, and Oral Contraception
The preponderance of female patients with otosclero-
sis has led to speculation that estrogen signaling may be
involved in the etiology of the disease (26–29). The
typical age of onset of otosclerosis is concurrent with
typical age of pregnancy and a link between the two has
been suggested although remains disputed (27,29). To
clarify the relationship of pregnancy and hormones with
otosclerosis, female specific questionnaire data were
examined in more detail (Table 3). From the 424 women
in the cohort, there were 409 responses for the female
only questionnaire, where 313 (77%) had experienced at
least one pregnancy (Preg_Y) and 96 had no history of
pregnancy (Preg_N). Age at recruitment is significantly
associated with pregnancy as might be expected since
younger female reported fewer pregnancies
( p¼ 1 106). Overall no significant differences were
observed in the age of onset, family history, bilateral
disease, incidence of tinnitus, or vertigo between Preg_Y
and Preg_N women providing no evidence for an inter-
action between pregnancy and risk of disease. Both
Preg_Y and Preg_N women have an earlier age of onset
than men, but very similar to each other (Fig. 2A).
However, 33% of Preg_Y women responded <Yes>
to ‘‘Did you notice any changes in your hearing ability
during your pregnancy/pregnancies?’’ When these third
of Preg_Y women who reported awareness of changes in
their hearing (Preg_HC) were compared with women that
reported no changes in their hearing during pregnancy
(Preg_NC), Preg_HC women were on average 4 years
younger at recruitment than Preg_NC women
( p¼ 6 103, Table 3). In addition, there was a highly
significant association between the reported age of onset
of otosclerosis and whether women reported a change
in hearing with pregnancy ( p¼ 6 106, Fig. 2B).
Preg_HC women have an earlier age of onset than both
men and Preg_NC women. The age of onset in Preg_NC
women is very similar to that of men. Hence, 43% of men
and 40% of Preg_NC women have onset of symptoms
before the age of 30, in contrast this figure rises to 65% of
Preg_HC women. Preg_N women also have a lower age
of onset, similar to that of Preg_HC women. One possi-
bility is that this might be related to long-term use of oral
contraceptives; 66% of Preg_N women have used oral
contraception for more than 5 years compared with 52%
of Preg_Y ( p¼ 0.049).
In the whole study group, women reported a higher
incidence of bilateral disease than men ( p¼ 0.03).
Preg_HC women reported a higher incidence of bilateral
hearing problems compared with Preg_N women and
men ( p¼ 0.04 and p¼ 7 103 respectively, Fig. 2C).
For Preg_HC women, a significantly higher proportion
breastfed after their pregnancies compared with Preg_NC
women (90% compared with 78%, p¼ 0.02). There was
no significant difference between Preg_HC and Preg_NC
women in the total time of breastfeeding (Fig. 2D) or in
the total number of pregnancies (Fig. 2E).
In previous studies, it has been reported that in a
proportion of women with otosclerosis a deterioration
26 M. CROMPTON ET AL.
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of hearing can occur during pregnancy (5,10,27). Similar
to these studies, it must be noted that the reporting of a
patient’s impression of deterioration of hearing during
pregnancy requires a subjective response. With that in
mind, our data further confirms that in a proportion of
women pregnancy leads to a deterioration of hearing.
Furthermore, our data suggest that in this significant
minority of women pregnancy may accelerate the pro-
gression of otosclerosis with a significant shift forward in
the age of onset in these women.
Measles Virus as a Risk Factor
The reported data on the role of measles infection in
the pathogenesis of otosclerosis has been contradictory.
In several studies, measles virus antigens and RNA have
been detected in otosclerotic foci and it was hypothesised
that this may be an inflammatory trigger during the active
phase of otosclerosis (30,31,33). In contrast, other studies
failed to demonstrate any viral antibodies in otosclerotic
foci or find any evidence of measles virus RNA in stapes
samples or bone cell cultures (32,34,36). We examined
the profile of otosclerosis comparing cases that reported
measles infection and cases without measles infection
(Table S3, Supplemental Digital Content 3, http://link-
s.lww.com/MAO/A690). Age at recruitment was signifi-
cantly associated with measles infection which might be
expected as more older patients who did not receive
vaccination reported measles infection. Interestingly,
patients with measles infection report a significantly later
age of otosclerosis onset than subjects with no measles
infection, with a mode age of onset in the 4th decade
compared with 3rd decade, respectively ( p¼ 2 103;
Figure S1, Supplemental Digital Content 3, http://link-
s.lww.com/MAO/A690).
Hence, we find no evidence to support a relationship
between measles infection and risk of otosclerosis in our
British cohort. Previously, studies in German cohorts
have suggested that the incidence of otosclerosis has
declined since the introduction of measles vaccination
(35), as well as highlighting the increasing age of oto-
sclerosis patients at the time of surgery over this period
(48). Similar to the contradictions with measles virus
antigens and RNA studies, our data do not support
previous suggestions that measles infection is an otoscle-
rosis risk factor. However, there is still a need for a
definitive study that does not rely on retrospective self-
reporting of measles infections which may explain our
failure to detect an association here.
Audiometry and Surgery
Audiological data were obtained from 154 subjects
and the demographics of this study population was
TABLE 3. Demographic characteristics of female otosclerosis cases stratified by the effect of pregnancy on hearing loss
Variables
Preg_Y
(n¼ 313)
Preg_N
(n¼ 96) p-value
Preg_HC
(n¼ 100)
Preg_NC
(n¼ 204) p-value
Age at consent Years (meanSD) 52 12.8 44 14.5 1x10S6 49 12.5 53 12.8 6T 10S3
Age of onset 10 years
11–20 years
21–30 years
31–40 years
41–50 years
51 years
6%
11%
32%
29%
18%
4%
8%
15%
36%
29%
10%
2%
0.27 6%
14%
45%
32%
3%
0%
6%
9%
25%
28%
26%
6%
6T 10S6
Family history Familial
Non-familial
41%
59%
45%
55%
0.54 41%
59%
40%
60%
0.99
Hearing loss Bilateral
Unilateral
68%
32%
58%
42%
0.10 73%
27%
65%
35%
0.21
Tinnitus Yes
No
69%
31%
77%
23%
0.19 72%
28%
69%
31%
0.72
Vertigo Yes
No
36%
64%
27%
73%
0.17 32%
68%
37%
63%
0.45
Number of pregnancies 1
2
3
4
5þ
n/a n/a n/a 15%
37%
26%
15%
7%
20%
45%
25%
6%
4%
0.07
Breastfed Yes
No
n/a n/a n/a 90%
10%
78%
22%
0.02
Time spent breastfeeding <1 month
2–5 months
6–12 months
>1 year
n/a n/a n/a 11%
21%
27%
40%
20%
23%
28%
29%
0.19
Oral contraception 5 years
>5 years
48%
52%
34%
66%
0.05 46%
54%
49%
51%
0.69
Preg_HC indicates pregnant with hearing changes; Preg_N, no history of pregnancy; Preg_NC, pregnant no hearing changes; Preg_Y, history
of pregnancy; SD, standard deviation. Significant differences in bold.
p< 0.05
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consistent with our main cohort (Table S4, Supplemental
Digital Content 3, http://links.lww.com/MAO/A690).
The audiometric results from our study are presented
in Table S5 and S6 (see Supplemental Digital Content 3,
http://links.lww.com/MAO/A690). The mean preopera-
tive pure-tone average (PTA) air-conduction (AC) thresh-
old was 57 dB HL, and the bone-conduction (BC) was
28 dB HL. The air-bone gap (ABG) was 29 dB. After
surgery, the corresponding results were AC 31dB HL,
BC25 dBHL, andABG5dB. Themean hearing gain after
surgery, expressed as improvement of the AC, was 27 dB
and in 75%of patients theAC threshold improved bymore
than 20 dB. After surgery, the BC was maintained or not
worsened bymore than 5 dB in 86%of the patients. In 88%
of patients, the postoperative ABG was within less than or
equal to 10 dB, and in 98% it was within 20 dB. Impor-
tantly, the mean pure-tone air and bone hearing thresholds
of our cohort are consistent with those of other published
cohorts (41,46).
As highlighted above, clinical differences can be
observed in the epidemiology and severity of otosclerosis
between groups and we wanted to evaluate whether these
differences are reflected in pre- and postoperative audio-
metric thresholds between groups. We compared AC,
BC, and ABG between male and female patients
(Figure S2A-C, Supplemental Digital Content 3, http://
links.lww.com/MAO/A690) and no significant differen-
ces were observed in the preoperative data. However, in
postoperative data male patients had a significantly
higher ABG (7 dB male and 5 dB female; p¼ 0.04). Even
though this is significant, the surgical outcome would
still be considered successful. When comparing familial
and non-familial surgical patients no significant differ-
ences were observed (Figure S2D-F, Supplemental Digi-
tal Content 3, http://links.lww.com/MAO/A690).
Finally, we compared hearing thresholds between
Preg_Y and Preg_N women (Figure S3A-C, Supplemen-
tal Digital Content 3, http://links.lww.com/MAO/A690)
and found no significant differences, which is consistent
with other published data (29). Even when we compared
Preg_HC and Preg_NCwomen no significant impact was
observed (Figure S3D-F, Supplemental Digital Content
3, http://links.lww.com/MAO/A690).
Similar surgical outcomes between subgroups are
perhaps understandable considering the relatively
short-term follow-up of the study and participants would
have sought medical advice at a point when their hearing
loss constitutes a disability. This is more likely to be the
case the greater the hearing loss, rather than the duration
of the hearing loss. It would therefore be more informa-
tive to undertake a prospective study beginning from the
age of onset of otosclerosis to evaluate whether clinical
differences observed in the epidemiology and severity of
otosclerosis can be reflected in hearing thresholds
between groups. Additionally, these results suggest that
while disease processes may be distinct between groups,
FIG. 2. Comparison of otosclerosis characteristics in patientswhen stratified by the effect of pregnancy on hearing loss. (A) Age of onset in
women who had experienced pregnancy (Preg_Y, n¼313) and those that had not (Preg_N, n¼96). (B) Age of onset in women who report
changes in hearing associated with pregnancy (Preg_HC, n¼100) and those who report no change during pregnancy (Preg_NC, n¼204).
(C) Bilateral hearing loss in pregnancy subgroups. (D) Time spent breastfeeding and (E) number of pregnancies in Preg_HC and Preg_NC
women. Male data used as control comparison in panels A to C (n¼233). ns indicates not significant; , p<0.05; , p<0.01; ,
p<0.0001.
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the effect they have on the stapes footplate and bone
conduction are similar.
CONCLUSION
In summary, this study has identified that familial otoscle-
rosis has a more rapid onset, with a higher incidence of
bilateral disease than non-familial otosclerosis. This is the
first study to identify differences in the degree of clinical
severity between familial and non-familial cases of otoscle-
rosis. Therefore, suggesting that more than one etiologymay
be involved and highlighting a need for further investigation.
In addition, we have found further evidence to support the
hypothesis that women are at a higher risk of developing
clinical otosclerosis than men and pregnancy may accelerate
disease progression, at least in a proportion of women.
Despite these differences in otosclerosis onset and progres-
sion, patients choose to undergo surgery at similar times,with
similar outcomes. Finally, ourBritish otosclerosis cohort also
confirms several characteristics largely consistent with pre-
vious published literature, including age of onset, sex ratio,
family history, and hearing loss symptoms associated with
otosclerosis. Otosclerosis is a common cause of adult-onset
hearing loss, resulting in a significant annual surgical load.
There remain several unresolved questions with respect to
certain etiological factors that continue to limit the confi-
dence of evidence-based patient information. We believe
there is a further need for modern cohort observations,
including longitudinal studies, and that our present cohort
adds significantly to the literature on this elusive disease.
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